Chris Dufton
Pharmaceutical development leader with more than 25 years of clinical research experience and a proven track record generating... | 165 Conifer Drive, Nederland, United States
*50 free lookup(s) per month.
No credit card required.
Chris Dufton’s Emails ch****@ar****.com
Chris Dufton’s Phone Numbers 1720940****
Social Media
Chris Dufton’s Location 165 Conifer Drive, Nederland, United States
Chris Dufton’s Expertise Pharmaceutical development leader with more than 25 years of clinical research experience and a proven track record generating positive results. Substantial expertise in Phase 1-4 clinical development, including pharmacokinetic, dose-identification, pivotal efficacy/safety, and label expansion studies. Strategic and hands-on regulatory experience in the US and EU with complex proposals such as Orphan Drug, Fast Track, SPA and CTD/NDA submissions. Directed post-approval clinical activities related to commercial launch, Phase 4 development, and publication plans. Specialties: Phase 1-4 clinical development, regulatory strategy, medical communications/publications
Chris Dufton’s Current Industry Edgewise Therapeutics
Chris
Dufton’s Prior Industry
University Of Colorado Hospital
|
Myogen
|
Gilead Sciences
|
Rubicon Sciences
|
Arca Biopharma
|
Incarda Therapeutics
|
Edgewise Therapeutics
Not the Chris Dufton you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Edgewise Therapeutics
Vice President, Clinical Development Operations
Thu Jun 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Incarda Therapeutics
Senior Vice President, Clinical Development
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Sep 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Arca Biopharma
Vice President, Clinical Development
Mon Jul 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Rubicon Sciences
Consultant
Thu Apr 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jun 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Gilead Sciences
Director of Clinical Research
Fri Dec 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Mar 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Myogen
Associate Director of Clinical Science
Mon Nov 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Nov 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Myogen
Clinical Scientist I/II
Mon Oct 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Oct 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Colorado Hospital
Research Associate
Sun Mar 01 1992 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Aug 01 1995 00:00:00 GMT+0000 (Coordinated Universal Time)Skills
Languages
Chris Dufton Email Addresses
Chris Dufton Phone Number
FAQ About Chris Dufton
-
Chris Dufton is located at
165 Conifer Drive, Nederland, United States -
Chris Dufton is a
Pharmaceutical development leader with more than 25 years of clinical research experience and a proven track record generating positive results. Substantial expertise in Phase 1-4 clinical development, including pharmacokinetic, dose-identification, pivotal efficacy/safety, and label expansion studies. Strategic and hands-on regulatory experience in the US and EU with complex proposals such as Orphan Drug, Fast Track, SPA and CTD/NDA submissions. Directed post-approval clinical activities related to commercial launch, Phase 4 development, and publication plans. Specialties: Phase 1-4 clinical development, regulatory strategy, medical communications/publications Edgewise Therapeutics -
Chris Dufton currently works in the
Edgewise Therapeutics -
Chris Dufton specializes in
Pharmaceutical development leader with more than 25 years of clinical research experience and a proven track record generating positive results. Substantial expertise in Phase 1-4 clinical development, including pharmacokinetic, dose-identification, pivotal efficacy/safety, and label expansion studies. Strategic and hands-on regulatory experience in the US and EU with complex proposals such as Orphan Drug, Fast Track, SPA and CTD/NDA submissions. Directed post-approval clinical activities related to commercial launch, Phase 4 development, and publication plans. Specialties: Phase 1-4 clinical development, regulatory strategy, medical communications/publications -
Chris Dufton speaks the following languages:
No languages available. -
Chris Dufton has prior experience in the following industries:
Incarda Therapeutics , Arca Biopharma , Rubicon Sciences , Gilead Sciences , Myogen , Myogen , University Of Colorado Hospital -
Chris Dufton has the following professional experience:
Edgewise Therapeutics , Incarda Therapeutics , Arca Biopharma , Rubicon Sciences , Gilead Sciences , Myogen , Myogen , University Of Colorado Hospital . -
You can view Chris Dufton’s
LinkedIn profile at LinkedIn URL. -
Chris Dufton’s work email addresses are
[email protected] . -
Chris Dufton works at
Edgewise Therapeutics
People you may be interested in
- Monica Hernandez
- Rana Pratap Singh
- Hiram Stratton
- Carolyn Edwards
- Kelli Schroeder
- Joe Ariganello
- Richard Peers
Phlebotomist
Scientist B (Medical) at Translational health science and technology institute
President
Textiles Professional
DHHS- Social Worker
Account Executive
Consultant